Copyright: ©Author(s) 2026.
World J Gastroenterol. Sep 21, 2026; 32(35): 118836
Published online Sep 21, 2026. doi: 10.3748/wjg.118836
Published online Sep 21, 2026. doi: 10.3748/wjg.118836
Table 2 Strategies to mitigate polyethylene glycol-associated dysbiosis while preserving bowel cleansing efficacy
| Strategy | Proposed mechanism | Potential benefit | Current evidence |
| Split-dose PEG[58] | Reduced continuous osmotic stress | Faster microbiota recovery | Clinical |
| Low-volume PEG formulations[58] | Lower luminal osmotic burden | Reduced ecological disruption | Emerging clinical |
| Probiotics[54-57] | Restoration of microbial balance | Reduced GI symptoms and faster recovery | Clinical + meta-analysis |
| Prebiotic/fiber-enriched diets[53] | Support of SCFA-producing bacteria | Enhanced microbial resilience | Clinical observational |
| Butyrate/glutamine supplementation[59,60] | Barrier protection and epithelial repair | Reduced permeability and inflammation | Experimental |
- Citation: Melgaço ACC, Alves AF, Pessoa WFB. Polyethylene glycol-based bowel preparation and gut dysbiosis: Clinical implications beyond colon cleansing. World J Gastroenterol 2026; 32(35): 118836
- URL: https://www.wjgnet.com/1007-9327/full/v32/i35/118836.htm
- DOI: https://dx.doi.org/10.3748/wjg.118836